WebPubMed; Scopus (47) Google Scholar). These findings lend support to the hypothesis that continued bone loss in long‐term renal transplant patients is associated with high bone‐turnover. If accelerated bone resorption does play a role in post‐transplant bone loss, this would provide a strong rationale for the use of antiresorptive therapy ... WebMyo-inositol hexaphosphate (phytate; IP6) is a natural compound that is abundant in cereals, legumes, and nuts, and it can bind to crystal surfaces and disturb crystal development, acting as crystallization inhibitor. The adsorption of such inhibitors to crystal faces can also inhibit crystal dissolution. The binding of phytate to metal cofactors …
Alendronate Uses, Side Effects & Warnings - Drugs.com
WebFeb 1, 2024 · Alendronate is used to prevent and treat osteoporosis (thinning of the bone) in women after menopause. This medicine may also be used to increase bone mass in men who have osteoporosis, and in men and women to prevent and treat osteoporosis caused by long-term use of corticosteroids (cortisone-like medicine). WebMagnesium-rich supplements or medications can decrease the absorption of oral bisphosphonates, such as alendronate (Fosamax®), used to treat osteoporosis ... Expert Rev Neurother 2009;9:369–79 [PubMed abstract] Schürks M, Diener H-C, Goadsby P. Update on the prophylaxis of migraine. Cur Treat Options Neurol 2008;10:20–9. … briefcase\u0027s to
National Center for Biotechnology Information
WebOct 10, 2024 · Alendronate is used to treat osteoporosis caused by menopause, steroid use, or gonadal failure. alendronate is for use when you have a high risk of bone … WebAims: To highlight the outcome of treatment of CPT with the Ilizarov procedure, bone graft, and use of bisphosphonate (sodium alendronate). Patients and methods: This is a retrospective study of five patients treated for CPT using the Ilizarov procedure, bone graft, and use of bisphosphonate in the Delta State University Teaching Hospital ... WebHowever, our findings differ from recent alendronate, risedronate, and ibandronate studies, which revealed a decrease in OC precursors (CD14 + /CD11b + cells).[17 – 19] In addition, direct sampling of the bone marrow revealed decreased osteoclastogenesis during alendronate treatment. briefcase\\u0027s tl